Human T cell development, localization, and function throughout life

BV Kumar, TJ Connors, DL Farber - Immunity, 2018 - cell.com
Throughout life, T cells coordinate multiple aspects of adaptive immunity, including
responses to pathogens, allergens, and tumors. In mouse models, the role of T cells is …

The role of the thymus in the immune response

P Thapa, DL Farber - Thoracic surgery clinics, 2019 - thoracic.theclinics.com
The thymus is an organ that is critically important to the immune system, which serves as the
body's defense mechanism, providing surveillance and protection against diverse …

Site-specific development and progressive maturation of human tissue-resident memory T cells over infancy and childhood

TJ Connors, R Matsumoto, S Verma, PA Szabo… - Immunity, 2023 - cell.com
Infancy and childhood are critical life stages for generating immune memory to protect
against pathogens; however, the timing, location, and pathways for memory development in …

Chromosome 22q11. 2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome)

DM McDonald-McGinn, KE Sullivan - Medicine, 2011 - journals.lww.com
Abstract Chromosome 22q11. 2 deletion syndrome is a common syndrome also known as
DiGeorge syndrome and velocardiofacial syndrome. It occurs in approximately 1: 4000 …

Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11. 2 deletion syndromes

LJ Kobrynski, KE Sullivan - The Lancet, 2007 - thelancet.com
Velocardiofacial syndrome, DiGeorge syndrome, and some other clinical syndromes have in
common a high frequency of hemizygous deletions of chromosome 22q11. 2. This deletion …

Chromosome 22q11. 2 deletion syndrome and DiGeorge syndrome

KE Sullivan - Immunological Reviews, 2019 - Wiley Online Library
Summary Chromosome 22q11. 2 deletion syndrome is the most common microdeletion
syndrome in humans. The effects are protean and highly variable, making a unified …

Development of population-based newborn screening for severe combined immunodeficiency

K Chan, JM Puck - Journal of Allergy and Clinical Immunology, 2005 - Elsevier
BACKGROUND: Severe combined immunodeficiency (SCID) is a treatable, inherited lack of
cellular and humoral immunity caused by diverse mutations in several different genes and …

Commercialization of regenerative-medicine therapies

T Takahashi, RP Donahue, RC Nordberg… - Nature Reviews …, 2023 - nature.com
The clinical translation of regenerative-medicine products, including cell therapies,
therapeutic tissue engineering products, and human cell and tissue products, remains …

Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants

ML Markert, BH Devlin, MJ Alexieff, J Li, EA McCarthy… - Blood, 2007 - ashpublications.org
The purpose of this study was to characterize a large group of infants with complete
DiGeorge anomaly and to evaluate the ability of thymus transplantation to reconstitute …

Severe combined immunodeficiency. A model disease for molecular immunology and therapy

A Fischer, F Le Deist, S Hacein‐Bey‐Abina… - Immunological …, 2005 - Wiley Online Library
Severe combined immunodeficiencies (SCIDs) consist of genetically determined arrest of T‐
cell differentiation. Ten different molecular defects have now been identified, which all lead …